Stocks Overview

LAST PRICE
41.4800
TODAY'S CHANGE (%)
Trending Down-2.6700 (-6.0476%)

Bid / Lots
40.0000/ 1
Ask / Lots
44.9700/ 1
Open / Previous Close
42.9500 / 44.1500
Day Range
Low 41.3800
High 43.7250
52 Week Range
Low 6.4000
High 44.3300
Volume
1,018,142
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 44.15
Time	Volume	DYN
09:32 ET	4813	42.16
09:34 ET	4577	42.21
09:36 ET	2100	42.39
09:38 ET	2485	42.43
09:39 ET	350	42.47
09:41 ET	3044	42.48
09:43 ET	2067	42.72
09:45 ET	900	42.5955
09:48 ET	200	42.78
09:50 ET	1596	42.61
09:52 ET	1630	43.04
09:54 ET	1480	43.46
09:56 ET	2841	43.47
09:57 ET	3190	43.26
09:59 ET	4832	43.065
10:01 ET	18879	42.77
10:03 ET	6573	42.595
10:06 ET	1330	42.59
10:08 ET	1467	42.44
10:10 ET	998	42.235
10:12 ET	800	42.32
10:14 ET	1850	42.48
10:15 ET	1100	42.55
10:17 ET	500	42.55
10:21 ET	4246	42.43
10:24 ET	400	42.575
10:26 ET	600	42.53
10:28 ET	5474	42.55
10:30 ET	800	42.62
10:32 ET	6336	42.34
10:33 ET	500	42.345
10:35 ET	14045	42.065
10:37 ET	4800	41.97
10:39 ET	36882	41.96
10:42 ET	3150	42.04
10:44 ET	1716	42.06
10:46 ET	2250	42.095
10:48 ET	900	42.28
10:50 ET	462	42.29
10:51 ET	1850	42.26
10:53 ET	1171	42.27
10:55 ET	1475	42.22
10:57 ET	450	42.2
11:00 ET	800	42.165
11:02 ET	1700	42.34
11:04 ET	2235	42.315
11:06 ET	200	42.325
11:08 ET	400	42.33
11:09 ET	1300	42.46
11:11 ET	1847	42.535
11:13 ET	400	42.545
11:15 ET	400	42.62
11:18 ET	100	42.625
11:20 ET	1600	42.85
11:22 ET	500	42.765
11:24 ET	2454	42.715
11:26 ET	1061	42.715
11:27 ET	2144	42.72
11:29 ET	1951	42.69
11:31 ET	1816	42.67
11:33 ET	5659	42.63
11:36 ET	1175	42.595
11:38 ET	1700	42.465
11:40 ET	2650	42.66
11:42 ET	1900	42.485
11:44 ET	300	42.3
11:45 ET	600	42.335
11:47 ET	1850	42.43
11:49 ET	500	42.475
11:51 ET	855	42.47
11:54 ET	100	42.47
11:56 ET	500	42.54
11:58 ET	1120	42.55
12:00 ET	1717	42.52
12:02 ET	202	42.58
12:03 ET	230	42.58
12:05 ET	5450	42.485
12:07 ET	700	42.39
12:09 ET	300	42.405
12:12 ET	400	42.355
12:14 ET	1918	42.32
12:16 ET	2100	42.33
12:18 ET	2500	42.335
12:20 ET	500	42.335
12:21 ET	600	42.24
12:23 ET	653	42.25
12:25 ET	1500	42.15
12:27 ET	300	42.135
12:30 ET	919	42.03
12:32 ET	200	42.035
12:34 ET	750	42.015
12:36 ET	1570	41.835
12:38 ET	900	41.73
12:39 ET	3498	41.885
12:41 ET	1950	41.815
12:43 ET	1700	41.78
12:45 ET	800	41.66
12:48 ET	3252	41.88
12:50 ET	2250	41.905
12:52 ET	900	41.9
12:54 ET	2901	42.04
12:56 ET	2200	42.05
12:57 ET	1398	41.98
12:59 ET	470	41.98
01:01 ET	705	41.975
01:03 ET	800	42.05
01:06 ET	4150	42.105
01:08 ET	500	42.085
01:10 ET	701	42.085
01:12 ET	2548	42.07
01:14 ET	100	42.09
01:15 ET	400	42.12
01:17 ET	2801	42.2
01:19 ET	1000	42.195
01:21 ET	4564	42.18
01:24 ET	3956	42.26
01:26 ET	600	42.32
01:28 ET	2500	42.19
01:30 ET	700	42.16
01:32 ET	2670	42.265
01:33 ET	1650	42.35
01:35 ET	500	42.355
01:37 ET	2200	42.45
01:39 ET	1915	42.32
01:42 ET	1309	42.3
01:44 ET	300	42.28
01:46 ET	1768	42.2
01:48 ET	1761	42.225
01:50 ET	21588	42.145
01:51 ET	900	42.1
01:53 ET	350	42.04
01:55 ET	918	41.92
01:57 ET	681	41.935
02:00 ET	400	41.94
02:02 ET	2034	42.04
02:04 ET	1468	42.02
02:06 ET	1437	41.95
02:08 ET	5178	41.985
02:09 ET	1046	41.91
02:11 ET	1764	41.98
02:13 ET	1200	41.975
02:15 ET	5551	41.98
02:18 ET	200	41.985
02:20 ET	200	41.985
02:22 ET	7367	41.93
02:24 ET	550	41.905
02:26 ET	1100	41.985
02:27 ET	500	41.85
02:29 ET	200	41.93
02:31 ET	3210	41.93
02:33 ET	500	41.935
02:36 ET	100	41.92
02:38 ET	2200	42
02:42 ET	2533	41.955
02:44 ET	4000	41.88
02:45 ET	1447	41.87
02:47 ET	2032	41.86
02:49 ET	1400	41.842
02:51 ET	1795	41.77
02:54 ET	1486	41.72
02:56 ET	2200	41.69
03:00 ET	1606	41.7
03:02 ET	3222	41.81
03:03 ET	1698	41.7
03:05 ET	2903	41.71
03:07 ET	2021	41.81
03:09 ET	3389	41.805
03:12 ET	3990	41.8
03:14 ET	8751	41.81
03:16 ET	2650	41.81
03:18 ET	1301	41.745
03:20 ET	2100	41.815
03:21 ET	2105	41.8
03:23 ET	1750	41.78
03:25 ET	2550	41.8
03:27 ET	1650	41.69
03:30 ET	3460	41.7
03:32 ET	1619	41.71
03:34 ET	5796	41.67
03:36 ET	22070	41.725
03:38 ET	2141	41.64
03:39 ET	7784	41.4979
03:41 ET	2506	41.51
03:43 ET	200	41.54
03:45 ET	1800	41.5
03:48 ET	3828	41.51
03:50 ET	4062	41.465
03:52 ET	33614	41.73
03:54 ET	13150	41.71
03:56 ET	16268	41.44
03:57 ET	23031	41.485
03:59 ET	54478	41.48

Data delayed at least 15 minutes.

Jul 9, 2024
- DJ Dyne Therapeutics Is Maintained at Overweight by JP Morgan, from 11:10AM ET on Tuesday Jul 09, 2024 by Dow Jones
  11:10AM ET on Tuesday Jul 09, 2024 by Dow Jones
Jun 24, 2024
- Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE(TM) Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease, from 7:30AM ET on Monday Jun 24, 2024 by Dow Jones
  7:30AM ET on Monday Jun 24, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesDYN Dyne Therapeutics Inc	4.4B	-10.5x	---
United StatesIBRX Immunitybio Inc	4.4B	-5.8x	---
United StatesCRNX Crinetics Pharmaceuticals Inc	4.3B	-14.3x	---
United StatesIMVT Immunovant Inc	4.5B	-15.9x	---
United StatesRNA Avidity Biosciences Inc	5.0B	-15.3x	---
United StatesMRUS Merus NV	4.0B	-20.8x	---
As of 2024-07-17

Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. It also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.

Contact Information

Headquarters: 1560 Trapelo RoadWALTHAM, MA, United States 02451
Phone: 781-786-8230
Fax: 781-786-8866

Executives

Independent Chairman of the Board: Jason Rhodes
President, Chief Executive Officer, Director: John Cox
Chief Operating Officer: Susanna High
Senior Vice President, Head of Finance and Administration: Richard Scalzo
Chief Scientific Officer: Oxana Beskrovnaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$4.4B
Revenue (TTM)	$0.00
Shares Outstanding	99.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.12
EPS	$-3.97
Book Value	$1.49
P/E Ratio	-10.5x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Dyne Therapeutics Inc
NASDAQ:DYNUnited States

Search Criteria

Charts

Recent News

Jul 9, 2024

DJ Dyne Therapeutics Is Maintained at Overweight by JP Morgan, from 11:10AM ET on Tuesday Jul 09, 2024 by Dow Jones

Jun 24, 2024

Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE(TM) Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease, from 7:30AM ET on Monday Jun 24, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar